NME4 suppresses NFκB2-CCL5 axis, restricting CD8+ T cell tumour infiltration in oesophageal squamous cell carcinoma

Shutao Zheng1, Shuo He1, Yan Liang1

  • 1State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.

Immunology
|July 17, 2024
PubMed

Insights

NME4, a metastasis-associated gene, hinders CD8+ T cell infiltration in oesophageal squamous cell carcinoma (ESCC) by regulating the NFκB2-CCL5 axis, impacting the tumor microenvironment.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • NME/NM23 nucleoside diphosphate kinase 4 (NME4) is recognized as a metastasis-associated gene.
  • Its role within the tumor microenvironment, particularly in oesophageal squamous cell carcinoma (ESCC), remains underexplored.

Purpose of the Study:

  • To investigate the immunological implications of NME4 expression in ESCC.
  • To elucidate the molecular mechanisms underlying NME4's function in the tumor microenvironment.

Main Methods:

  • Multiplex immunohistochemistry was employed to assess NME4 expression in ESCC patients.
  • A syngeneic murine ESCC model (C57BL/6) was established for in vivo studies.
  • Single-cell RNA sequencing, quantitative proteomics, and protein microarray screening were utilized to explore molecular pathways.

Main Results:

  • NME4 expression showed limited clinicopathological and prognostic significance in human ESCC.
  • In vivo, NME4 significantly inhibited CD8+ T cell infiltration into the tumor microenvironment of murine ESCC.
  • The NFκB2-CCL5 signaling axis was identified as a key pathway negatively regulated by NME4.

Conclusions:

  • NME4 plays a critical role in preventing CD8+ T cell infiltration in ESCC.
  • The mechanism involves NME4's regulation of the NFκB2-CCL5 axis, impacting the tumor immune microenvironment.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
885
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K